164 related articles for article (PubMed ID: 9433866)
1. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
Cid MC; Font C; Oristrell J; de la Sierra A; Coll-Vinent B; López-Soto A; Vilaseca J; Urbano-Márquez A; Grau JM
Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
[TBL] [Abstract][Full Text] [Related]
3. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
[TBL] [Abstract][Full Text] [Related]
4. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
[TBL] [Abstract][Full Text] [Related]
6. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
[TBL] [Abstract][Full Text] [Related]
7. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
8. No association between the inflammatory response and the risk of developing irreversible cranial ischemic complications: comment on the article by Cid et al.
Nesher G; Sonnenblick M
Arthritis Rheum; 1998 Nov; 41(11):2088-9. PubMed ID: 9811070
[No Abstract] [Full Text] [Related]
9. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
10. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
11. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
Salvarani C; Hunder GG
Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Della Bella C; Cimino L; Macchioni P; Formisano D; Bajocchi G; Pipitone N; Catanoso MG; Restuccia G; Ghinoi A; Boiardi L
Rheumatology (Oxford); 2009 Mar; 48(3):250-3. PubMed ID: 19109317
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Lee MS; Smith SD; Galor A; Hoffman GS
Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
[TBL] [Abstract][Full Text] [Related]
14. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.
Gonzalez-Gay MA; Garcia-Porrua C; Llorca J; Gonzalez-Louzao C; Rodriguez-Ledo P
Semin Arthritis Rheum; 2001 Feb; 30(4):249-56. PubMed ID: 11182025
[TBL] [Abstract][Full Text] [Related]
15. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
17. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
18. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
González-Gay MA; Blanco R; Rodríguez-Valverde V; Martínez-Taboada VM; Delgado-Rodriguez M; Figueroa M; Uriarte E
Arthritis Rheum; 1998 Aug; 41(8):1497-504. PubMed ID: 9704651
[TBL] [Abstract][Full Text] [Related]
19. Comparison of histopathologic features, clinical symptoms, and erythrocyte sedimentation rates in biopsy-positive temporal arteritis.
Diaz VA; DeBroff BM; Sinard J
Ophthalmology; 2005 Jul; 112(7):1293-8. PubMed ID: 15921755
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis.
Lincoff NS; Erlich PD; Brass LS
J Neuroophthalmol; 2000 Jun; 20(2):67-72. PubMed ID: 10870916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
